Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples